Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2020
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor
Fadi Taza, Michal Chovanec, Anna Snavely, et al.
European Urology
|
October 4, 2022
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
Urologic Oncology
|
September 26, 2022
Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns
Isamu Tachibana, Ruben Vasquez, Mohammad Mahmoud, et al.
Journal of Pain and Symptom Management
|
January 8, 2025
Correlates of Perceived Illness Severity and Terminality in Advanced Lung and Prostate Cancer
Michaela Di Palmo, Ekin Secinti, Ellen Krueger, et al.
Cancer
|
May 20, 2024
High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience
Noah H Richardson, Fadi Taza, Rafat Abonour, et al.
JNCI Cancer Spectrum
|
March 20, 2020
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management
Vaibhav Agrawal, Paul C Dinh, Chunkit Fung, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 28, 2020
Molecular Characterization of Testicular Germ Cell Tumors Using Tissue Microdissection
Liang Cheng, Steven A Mann, Antonio Lopez-Beltran, et al.
Nucleic Acids Research
|
February 14, 2019
Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA
Alexander R Gawroński, Yen-Yi Lin, Brian McConeghy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2023
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
Isamu Tachibana, Andre Alabd, Yan Tong, et al.
Psycho-Oncology
|
November 7, 2022
Relations of perceived injustice to psycho-spiritual outcomes in advanced lung and prostate cancer: Examining the role of acceptance and meaning making
Ekin Secinti, Wei Wu, Ellen F Krueger, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2020
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor
Fadi Taza, Michal Chovanec, Anna Snavely, et al.
European Urology
|
October 4, 2022
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
Urologic Oncology
|
September 26, 2022
Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns
Isamu Tachibana, Ruben Vasquez, Mohammad Mahmoud, et al.
Journal of Pain and Symptom Management
|
January 8, 2025
Correlates of Perceived Illness Severity and Terminality in Advanced Lung and Prostate Cancer
Michaela Di Palmo, Ekin Secinti, Ellen Krueger, et al.
Cancer
|
May 20, 2024
High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience
Noah H Richardson, Fadi Taza, Rafat Abonour, et al.
JNCI Cancer Spectrum
|
March 20, 2020
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management
Vaibhav Agrawal, Paul C Dinh, Chunkit Fung, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 28, 2020
Molecular Characterization of Testicular Germ Cell Tumors Using Tissue Microdissection
Liang Cheng, Steven A Mann, Antonio Lopez-Beltran, et al.
Nucleic Acids Research
|
February 14, 2019
Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA
Alexander R Gawroński, Yen-Yi Lin, Brian McConeghy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2023
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
Isamu Tachibana, Andre Alabd, Yan Tong, et al.
Psycho-Oncology
|
November 7, 2022
Relations of perceived injustice to psycho-spiritual outcomes in advanced lung and prostate cancer: Examining the role of acceptance and meaning making
Ekin Secinti, Wei Wu, Ellen F Krueger, et al.
Page
of 10